" /> Icrucumab - CISMeF





Preferred Label : Icrucumab;

NCIt synonyms : Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody IMC-18F1; Anti-VEGFR-1 Monoclonal Antibody IMC-18F1;

NCIt definition : A fully human IgG1 monoclonal antibody directed against human vascular endothelial growth factor receptor 1 (VEGFR-1/FLT-1) with potential antiangiogenesis and antineoplastic activities. Icrucumab specifically binds to and inhibits the activity of VEGFR-1, which may prevent the activation of downstream signaling pathways and so inhibit tumor angiogenesis; the subsequent reduction in tumor nutrient supply may inhibit tumor cell proliferation. Tumor cell overexpression of VEGFR-1 may be associated with tumor angiogenesis and tumor cell proliferation and invasion; VEGFR-1 may modulate VEGFR-2 signaling.;

UNII : T7H0B1R64U;

CAS number : 1024603-92-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1024603-92-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : IMC-18F1;

Details


You can consult :


Nous contacter.
10/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.